High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy
出版年份 2015 全文链接
标题
High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy
作者
关键词
-
出版物
Molecular Oncology
Volume 10, Issue 1, Pages 138-147
出版商
Wiley
发表日期
2015-09-16
DOI
10.1016/j.molonc.2015.09.002
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues
- (2015) Carine Steiner et al. MOLECULAR & CELLULAR PROTEOMICS
- Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies
- (2015) Rocio Vicario et al. PLoS One
- Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab
- (2014) Huan Cheng et al. BMC CANCER
- Human Epidermal Growth Factor Receptor 2 Testing in Primary Breast Cancer in the Era of Standardized Testing: A Canadian Prospective Study
- (2014) Wedad M. Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Absolute Quantitation of Met Using Mass Spectrometry for Clinical Application: Assay Precision, Stability, and Correlation with MET Gene Amplification in FFPE Tumor Tissue
- (2014) Daniel V. T. Catenacci et al. PLoS One
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Application of Selected Reaction Monitoring for Multiplex Quantification of Clinically Validated Biomarkers in Formalin-Fixed, Paraffin-Embedded Tumor Tissue
- (2013) Todd Hembrough et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31
- (2013) Katherine L. Pogue-Geile et al. JNCI-Journal of the National Cancer Institute
- Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer
- (2013) Filippo Montemurro et al. Molecular Oncology
- Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
- (2013) David A. Nathanson et al. SCIENCE
- Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry
- (2012) Regine M. Schoenherr et al. PROTEOMICS
- HER2and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial
- (2010) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Disease-Free Survival According to Degree ofHER2Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation